Bladder Cancer Test Kit
| Sample Type | Urine |
| Applications | Bladder Cancer |
| Analysis Mode | Enzyme Immunoassay |
The Alere NMP22® Test Kit is an enzyme immunoassay (EIA) that is designed to quantify the nuclear mitotic apparatus protein (NuMA) in stabilized voided urine in vitro. NuMA is a prevalent component of the nuclear matrix proteins.Advantagesinput:
output:Nuclear Matrix Protein 22 is a protein that is ubiquitous in the nucleus of all cells. NMP22 is released into urine by bladder cancer cells. An NMP22-specific assay can detect elevated levels of NMP22 at the earliest stages of the disease, rendering it a marker for early diagnosis and monitoring in conjunction with standard diagnostic procedures.Oneinput:
output:The key to enhancing the likelihood of survival is the early detection of bladder cancer. Our test is a complementary procedure to cystoscopy that has enhanced the combined detection rate of bladder cancer and has a generally higher sensitivity than cytology.Two
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
